Nuvation Bio Inc.

This early-stage study tested a new oral drug called NUV-868, both alone and combined with two existing cancer medications (olaparib or enzalutamide), in adults with advanced solid tumors. The goal was to find safe doses and see if these treatments could help control cancers like…

This study tested an oral drug called AB-106 (taletrectinib) for people with advanced solid tumors that had spread and contained a specific genetic change called an NTRK fusion. The goal was to see if the drug could shrink or control these difficult-to-treat cancers. The trial wa…